FLSM
Frazier Life Sciences Management’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3M | Hold |
4,887,867
| – | – | 2.21% | 13 |
|
|
2025
Q1 | $56.4M | Hold |
4,887,867
| – | – | 2.58% | 11 |
|
|
2024
Q4 | $41.4M | Buy |
4,887,867
+1,200,000
| +33% | +$10.2M | 1.72% | 16 |
|
|
2024
Q3 | $42.7M | Hold |
3,687,867
| – | – | 1.71% | 19 |
|
|
2024
Q2 | $43.4M | Hold |
3,687,867
| – | – | 2.03% | 14 |
|
|
2024
Q1 | $43.7M | Buy |
3,687,867
+65,573
| +2% | +$778K | 1.85% | 17 |
|
|
2023
Q4 | $44.4M | Buy |
3,622,294
+383,435
| +12% | +$4.7M | 2.37% | 14 |
|
|
2023
Q3 | $31.2M | Hold |
3,238,859
| – | – | 2.07% | 14 |
|
|
2023
Q2 | $29.1M | Hold |
3,238,859
| – | – | 1.74% | 15 |
|
|
2023
Q1 | $25.5M | Hold |
3,238,859
| – | – | 1.84% | 12 |
|
|
2022
Q4 | $21.9M | Buy |
3,238,859
+1,666,667
| +106% | +$11.3M | 1.36% | 20 |
|
|
2022
Q3 | $22.8M | Hold |
1,572,192
| – | – | 1.76% | 17 |
|
|
2022
Q2 | $15.5M | Hold |
1,572,192
| – | – | 1.46% | 18 |
|
|
2022
Q1 | $23.2M | Buy |
+1,572,192
| New | +$23.2M | 1.98% | 16 |
|